Delivery Order SPE2DB22D1002-SPE2DB24FKXU9
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $4K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $4,428.64 delivery order contract by the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. The contract is a firm fixed price delivery order with a completion date of February 8, 2024. This award is under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver pharmaceutical products and medical supplies to DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,619.64 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY 2S. This $1,349.70 award has a completion date of February 7, 2024 and does not include any set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies,...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,443.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NARCAN 4 MG NASAL SPRAY medical products. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide 4,563,782,408 units of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. The $1,591.68 order has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NARCAN 4 MG NASAL SPRAY 2S with a potential value of $2,159.52. The order has a completion date of February 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award and holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NARCAN 4 mg nasal spray. The $1,591.68 contract has a completion date of March 29, 2024 and was awarded on March 28, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its Corporate Office location in Conshohocken, Pennsylvania to support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NARCAN 4 MG NASAL SPRAY 2S over a period ending on April 16, 2024. The contract, valued at $2,213.85, was awarded by the Defense Logistics Agency (DLA) under a Firm Fixed Price delivery order. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,591.68, is a firm fixed price delivery order for Narcan 4 mg nasal spray. Amerisourcebergen Drug Corp serves as the prime contractor and is responsible for providing this pharmaceutical product to support military treatment programs and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of NARCAN 4 MG NASAL SPRAY 2S. The contract has a potential value of $1,193.76 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this delivery order. The company also holds an indefinite delivery contract (IDC) with DLA, valued at...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB24FKXU9Delivery Order
Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, was awarded a $4,000.87 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide NARCAN 4 MG NASAL SPRAY 2S. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) that serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. The award was made on February 8, 2024, with a completion date of February 9, 2024.
Generated 5/9/24, 10:33 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 2/8/24 |